UBA1 and acute myeloid leukemia: We previously reported that acute myeloid leukemia (AML) cell lines and primary patient samples are more dependent on the activity of UBA1 compared with normal hematopoietic cells and thus are more vulnerable to UBA1 inhibition (7).